Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Toxins (Basel) ; 9(6)2017 06 13.
Artigo em Inglês | MEDLINE | ID: mdl-28608817

RESUMO

Spider envenomation, from the genus Loxosceles, is frequently reported as a cause of necrotic lesions in humans around the world. Among the many components found in the venom of Loxosceles genus, phospholipases D (PLDs) are the most investigated, since they can cause a massive inflammatory response, dermonecrosis, hemolysis and platelet aggregation, among other effects. Even though the PLDs induce strong platelet aggregation, there are no studies showing how the PLDs interact with platelets to promote this effect. Since many agonists must interact with specific receptors on the platelet membrane to induce aggregation, it is reasonable to expect that the PLDs may, in some way, also interact with platelets, to induce this activity. Therefore, to address this possibility, in this work, a recombinant PLD, called LgRec1, from L. gaucho was fused to enhanced green fluorescent protein (EGFP) and used as a probe to detect the interaction of LgRec1 to platelets, by fluorescence-activated cell sorter (FACS) and confocal microscopy. The preservation of biological activities of this chimera toxin was also analyzed. As a first, the results show that LgRec1 does not require plasma components to bind to platelets, although these components are necessary to LgRec1 to induce platelet aggregation. Also, the attachment of LgRec1 to human platelets' cell membranes suggests that the exposure of phosphatidylserine (PS) may act as a scaffold for coagulation factors. Therefore, the results add new information about the binding of Loxosceles PLDs to platelets, which may help unravel how these toxins promote platelet aggregation.


Assuntos
Plaquetas/efeitos dos fármacos , Fosfatidilserinas/metabolismo , Fosfolipase D/farmacologia , Aranhas/enzimologia , Animais , Plaquetas/fisiologia , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/farmacologia , Hemólise/efeitos dos fármacos , Humanos , L-Lactato Desidrogenase/metabolismo , Fosfolipase D/genética , Agregação Plaquetária/efeitos dos fármacos , Plasma Rico em Plaquetas , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/farmacologia
2.
Biochimie ; 95(9): 1773-83, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23770445

RESUMO

Loxosceles venom comprises a mixture of diverse toxins that induces intense local inflammatory reaction, dermonecrotic injury, platelet aggregation, hemolytic anemia and acute renal failure. Among several toxins in the venom, phospholipases D (PLDs), also called dermonecrotic toxins, are the most important and best studied, since they account for the main effects observed in loxoscelism. Despite their importance, biological analysis of PLDs is hampered by the minute amounts normally purified from the venom, and therefore many efforts have been made to clone those toxins. However, to date, no PLD from Loxosceles gaucho has been obtained in a heterologous system. Thus, in this work we show the cloning of a PLD from L. gaucho venom gland, named LgRec1, which was successfully expressed in a bacterial system. LgRec1 evoked local reaction (edema, erythema, ecchymosis, and paleness), dermonecrosis and hemolysis. It was also able to hydrolyze sphingomyelin and promote platelet aggregation. ELISA and Western blot analysis showed that LgRec1 was recognized by an anti-L. gaucho venom serum, a commercial arachnidic antivenom as well as a monoclonal antibody raised against the dermonecrotic fraction of L. gaucho venom. In addition, LgRec1 demonstrated to be highly immunogenic and antibodies raised against this recombinant toxin inhibited local reaction (~65%) and dermonecrosis (~100%) elicited by L. gaucho whole venom. Since PLDs are considered the major components accounting for the local and systemic envenomation effects caused by spiders from genus Loxosceles, the information provided here may help to understand the mechanisms behind clinical symptomatology.


Assuntos
Fosfolipase D/genética , Venenos de Aranha/genética , Sequência de Aminoácidos , Animais , Anticorpos Neutralizantes/imunologia , Sequência de Bases , Clonagem Molecular , Reações Cruzadas , Expressão Gênica , Hemólise/efeitos dos fármacos , Humanos , Dados de Sequência Molecular , Fosfolipase D/imunologia , Fosfolipase D/metabolismo , Fosfolipase D/farmacologia , Agregação Plaquetária/efeitos dos fármacos , Coelhos , Alinhamento de Sequência , Esfingomielina Fosfodiesterase/metabolismo , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...